The content on this site is intended for healthcare professionals only
Dr Eulade Rugengamanzi talk to ecancer about how Rwanda is experiencing a surge in multiple myeloma cases, necessitating increased focus, research, and advocacy. The planning and availability of treatment, particularly advanced options, are crucial. There's a need to improve late diagnosis and the perception of healthcare professionals. Research is essential to improve the management of multiple myeloma in Rwanda and Sub-Saharan Africa.
ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in localised prostate cancer
Transforming cancer care in India: The Access Cancer Care Initiative
Key insights from lung cancer research at ASCO 2025
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Tele-mentoring: Impact of project ECHO
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma In Rwanda: The need for further research
